Journal
CURRENT MEDICINAL CHEMISTRY
Volume 7, Issue 11, Pages 1145-1161Publisher
BENTHAM SCIENCE PUBL LTD
DOI: 10.2174/0929867003374255
Keywords
-
Ask authors/readers for more resources
Increasing amounts of experimental and clinical data support the role of selective cyclooxygenase (COX)-2 inhibition in anti-inflammatory processes and the involvement of COX-1 inhibition in the side effects associated with non steroidal anti-inflammatory drug use. This review will focus on the differences in the structure of the COX-1 and COX-2 molecules, particularly the active site and how they are bound by various NSAIDs to achieve COX-2 selectivity. This COX-2 selectivity will then be characterized in pharmacological assays in vitro and in animal models in vivo. finally, clinical information available for this new class of selective inhibitors will be discussed.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available